Journey Medical Corp (DERM)
3.93
+0.13
(+3.42%)
USD |
NASDAQ |
May 31, 16:00
3.93
0.00 (0.00%)
After-Hours: 20:00
Journey Medical Research and Development Expense (Annual): 7.541M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.541M |
| December 31, 2022 | 10.94M |
| Date | Value |
|---|---|
| December 31, 2021 | 16.56M |
| December 31, 2020 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
2020
16.56M
Maximum
2021
8.760M
Average
9.242M
Median
Research and Development Expense (Annual) Benchmarks
| Fortress Biotech Inc | 106.07M |
| Stereotaxis Inc | 10.27M |
| GT Biopharma Inc | 6.466M |
| Cara Therapeutics Inc | 108.51M |
| FibroGen Inc | 282.86M |